All articles tagged with #thrombectomy
Northern Ireland has launched a 24/7 thrombectomy service, making it the first UK region to provide round-the-clock emergency stroke treatment for its entire population. The £5m expansion, operational since September 14, doubles annual capacity to 300 procedures and ensures patients are no longer denied life-saving clot removal based on the time of day their stroke occurs.
A Florida teacher suffered a massive stroke at home on Aug. 8, 2025. His wife, a nurse, returned home, called 911, and he underwent a mechanical thrombectomy about 38 minutes later, restoring circulation with minimal lasting damage. He left the hospital in under 48 hours, returned to work four weeks later, and completed a 100‑mile bike ride two months after the stroke. Doctors later closed a patent foramen ovale to reduce future risk. He attributes the miraculous recovery to his wife’s quick decision that day.
A 14-hospital Spanish trial (CHOICE-2) tested delivering a low-dose alteplase directly into the brain after thrombectomy and found that treating tiny downstream vessels improved 90-day functional outcomes and reduced low-blood-flow patches, suggesting that simply reopening the main artery isn’t enough and that post-procedure alteplase could extend the recovery window, though safety signals require further study.
Boston Scientific plans to acquire Penumbra for about $14.5 billion in cash and stock, gaining Penumbra’s thrombectomy and embolization devices to broaden its vascular portfolio. The deal values Penumbra at $374 per share and is expected to close in 2026 pending shareholder and regulatory approvals, with Penumbra generating about $1.4 billion in revenue for 2025. Analysts say the price is fair and the acquisition aligns with a trend of medtech consolidation.
Boston Scientific announced a definitive agreement to acquire Penumbra in a cash-and-stock deal valued at about $14.5 billion (Penumbra at $374/share), creating a scaled entry into mechanical thrombectomy and neurovascular therapies. The transaction finances roughly 73% cash and 27% Boston Scientific stock (about $11 billion cash financed with cash on hand and new debt) and is expected to close in 2026 pending stockholder and regulatory approvals. Penumbra reported about $1.4 billion in revenue for 2025. Penumbra stockholders may elect cash or Boston Scientific shares; Adam Elsesser plans to take Boston Scientific stock for all his Penumbra shares. The deal is dilutive to GAAP earnings in the near term and to adjusted EPS in the near term, with accretion expected in later years.
Boston Scientific announced a cash-and-stock deal to acquire Penumbra for about $14.5 billion (Penumbra at $374 per share), expanding its cardiovascular portfolio with Penumbra’s mechanical thrombectomy and neurovascular tech. The transaction is ~73% cash and ~27% stock, financed with cash on hand and new debt, and is expected to close in 2026 after shareholder and regulatory approvals. Penumbra’s 2025 revenue is about $1.4 billion; the deal aims to broaden access to vascular therapies and drive long-term growth, though GAAP earnings are expected to be dilutive in the near term.
Doctors from Scotland and the US performed a world-first remote stroke thrombectomy using robotics, demonstrating that specialist surgeons can operate from anywhere, potentially transforming stroke treatment accessibility and timing.
Stanford researchers have developed the milli-spinner thrombectomy, a new device that significantly improves stroke treatment by shrinking blood clots without breaking them, potentially doubling the success rate of clot removal procedures and saving more lives.
Stanford researchers have developed a novel device called the milli-spinner that can more effectively and precisely remove blood clots causing strokes, potentially saving many patients' lives by significantly improving clot removal success rates compared to traditional methods.
Stanford researchers have developed the milli-spinner thrombectomy, a device that uses compression and shear forces to shrink and remove blood clots more effectively, potentially transforming stroke treatment and other medical procedures.
A 6-year-old boy in Illinois suffered a rare stroke caused by a blood clot linked to a flu infection, but was successfully treated with a thrombectomy, leading to a full reversal of symptoms and inspiring his desire to become a nurse.
Helen Brown, a 102-year-old woman from Akron, Ohio, became the oldest Cleveland Clinic patient to undergo a thrombectomy following a stroke. Despite her age, Brown was otherwise healthy and had a good family support system, which made her a good candidate for the procedure. Her family is urging people to recognize stroke symptoms and the importance of getting help quickly. Brown continues to defy the odds and walk around the house with assistance from a walker.
Bailey Novak, a nurse at Bryan Health, woke up paralyzed on half her body and realized she was having a stroke. She was able to call for help and underwent a thrombectomy at the hospital. Novak is now back to working full-time without any restrictions and is thankful for the support she received from colleagues, friends, and staff at the hospital. Doctors use the acronym "B.E. F.A.S.T" to help people remember what to look for in a stroke: Balance is suddenly lost, Eyes have a sudden change in vision, Face droops or feels weak, Arms or legs suddenly feel weak, Speech sounds slurred or strange, and Time to call 911 to get help as soon as possible.
Brad Coleman, a 36-year-old man from North Ogden, Utah, experienced a stroke last October, highlighting the increase in younger stroke patients. Dr. Melissa McDonald, stroke medical director at Intermountain McKay-Dee Hospital, said that strokes can happen to anyone, and one preventable cause is cracking the neck. The hospital recently received certification from The Joint Commission as the first nationally certified Thrombectomy-Capable Stroke Center in Utah. The thrombectomy procedure involves inserting a catheter in the hip area and guiding it up to the brain to remove the clot. The effects of a stroke depend on several factors, including how quickly it is treated.
Brad Coleman, a 36-year-old stroke victim, received quick and lifesaving treatment at McKay-Dee Hospital in northern Utah. He underwent a mechanical thrombectomy, a special emergency procedure that removed the clot in his brain that was causing the stroke and its symptoms. Due to a successful surgery, all his stroke symptoms were reversed. McKay-Dee Hospital recently became the first nationally certified thrombectomy-capable stroke center in Utah, qualifying the hospital for a specific protocol in which emergency technicians can bypass other hospitals and take patients directly to McKay-Dee for the lifesaving procedure.